Three-year follow-up of sirolimus-eluting stents vs. bare metal stents for acute myocardial infarction

Circulation Journal

Volumn 76, Issue 1, 2012, Pages 65-70

  Ejiri, Kentaro ^a,b   Ishihara, Masaharu ^a   Dai, Kazuoki ^a   Miki, Takashi ^a   Inoue, Ichiro ^a   Kawagoe, Takuji ^a   Shimatani, Yuji ^a   Miura, Fumiharu ^a   Nakama, Yasuharu ^a   Otani, Takayuki ^a   Ikenaga, Hiroki ^a   Oda, Nozomu ^a,c   Nakamura, Masayuki ^a  

^a HIROSHIMA CITY HOSPITAL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION OKAYAMA MEDICAL CENTER   (Japan)

^c Miyoshi Central Hospital   (Japan)

Author keywords

Drug eluting stents; Myocardial infarction; Percutaneous coronary intervention

Indexed keywords

RAPAMYCIN;

ACUTE HEART INFARCTION; AGED; ARTICLE; BARE METAL STENT; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DEATH; DRUG ELUTING STENT; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; STENT THROMBOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY ARTERY BYPASS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; JAPAN; LONGITUDINAL STUDIES; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; SIROLIMUS; STENTS; STROKE; TREATMENT OUTCOME;

EID: 84255183897     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0300     Document Type: Article

References (31)

1. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction: Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999; 341: 1949-1956.
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
3. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: A randomized controlled trial. JAMA 2005; 293: 165-171.
4. Saia F, Lemos PA, Lee CH, Arampatzis CA, Hoye A, Degertekin M, et al. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: A clinical and angiographic study. Circulation 2003; 108: 1927-1929.
5. Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrie D, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006; 355: 1093-1104.
6. Newell MC, Henry CR, Sigakis CJ, Unger BT, Larson DM, Chavez IJ, et al. Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction. Am J Cardiol 2006; 97: 1299-1302.
7. Choi CU, Rha SW, Chen KY, Li YJ, Poddar KL, Jin Z, et al. Lack of clinical benefit of improved angiographic results with sirolimuseluting stents compared with paclitaxel and zotarolimus-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Circ J 2009; 73: 2229-2235.
8. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231.
9. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351.
10. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007; 356: 1030-1039.
11. Ardissino D, Cavallini C, Bramucci E, Indolfi C, Marzocchi A, Manari A, et al. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: A randomized trial. JAMA 2004; 292: 2727-2734.
12. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007; 356: 1009-1019.
13. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
14. Wenaweser P, Daemen J, Zwahlen M, van Domburg R, Juni P, Vaina S, et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice: Four-year results from a large two-institutional cohort study. J Am Coll Cardiol 2008; 52: 1134-1140.
15. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007; 369: 667-678.
16. Kukreja N, Onuma Y, Garcia-Garcia HM, Daemen J, van Domburg R, Serruys PW. The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents. JACC Cardiovasc Interv 2009; 2: 534-541.
17. Inoue K. Drug-eluting stents are not indicated for patients with acute coronary syndrome: Should drug-eluting stents be indicated for patients with acute coronary syndrome? (Con) Circ J 2010; 74: 2232-2238.
18. Valgimigli M, Campo G, Arcozzi C, Malagutti P, Carletti R, Ferrari F, et al. Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa inhibitor infusion in patients with myocardial infarction: Results from the STRATEGY study. J Am Coll Cardiol 2007; 50: 138-145.
19. Spaulding C, Teiger E, Commeau P, Varenne O, Bramucci E, Slama M, et al. Four-year follow-up of TYPHOON (Trial to Assess the Use of the CYPHer Sirolimus-Eluting Coronary Stent in Acute Myocardial Infarction Treated With BallOON Angioplasty). JACC Cardiovasc Interv 2011; 4: 14-23.
20. Violini R, Musto C, De Felice F, Nazzaro MS, Cifarelli A, Petitti T, et al. Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: 3-year results of the SESAMI (sirolimus-eluting stent versus baremetal stent in acute myocardial infarction) trial. J Am Coll Cardiol 2010; 55: 810-814.
21. Di Lorenzo E, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, et al. Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: Four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial. Am Heart J 2009; 158: e43-e50.
22. Park KW, Kang SH, Chung WY, Lee HY, Park JS, Kang HJ, et al. 'Real world' comparison of drug-eluting stents vs bare metal stents in the treatment of unselected patients with acute ST-segment elevation myocardial infarction. Circ J 2010; 74: 1111-1120.
23. Kaltoft A, Kelbaek H, Thuesen L, Lassen JF, Clemmensen P, Klovgaard L, et al. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial. J Am Coll Cardiol 2010; 56: 641-645.
24. Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, et al. Antiplatelet therapy and stent thrombosis after sirolimuseluting stent implantation. Circulation 2009; 119: 987-995.
25. Kawaguchi R, Kimura T, Morimoto T, Oshima S, Hoshizaki H, Kawai K, et al. Safety and efficacy of sirolimus-eluting stent implantation in patients with acute coronary syndrome in the real world. Am J Cardiol 2010; 106: 1550-1560.
26. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, et al. Late stent malapposition after drug-eluting stent implantation: An intravascular ultrasound analysis with long-term follow-up. Circulation 2006; 113: 414-419.
27. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, et al. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation 2004; 109: 881-886.
28. Shimohama T, Ako J, Yamasaki M, Otake H, Tsujino I, Hasegawa T, et al. SPIRIT III JAPAN versus SPIRIT III USA: A comparative intravascular ultrasound analysis of the everolimus-eluting stent. Am J Cardiol 2010; 106: 13-17.
29. Horiguchi H, Yasunaga H, Hashimoto H, Matsuda S. Impact of drugeluting stents on treatment option mix for coronary artery disease in Japan. Circ J 2010; 74: 1635-1643.
30. Akasaka T. What can we expect in PCI in patients with chronic coronary artery disease: Indication of PCI for angiographically significant coronary artery stenosis without objective evidence of myocardial ischemia (Con). Circ J 2010; 75: 211-217; discussion 210.
31. Nakagawa Y. What is the effectiveness of drug-eluting stents in the treatment of ST-elevation myocardial infarction?: Should drug-eluting stents be indicated for patients with acute coronary syndrome? (Pro) Circ J 2010; 74: 2225-2231.